Watch our CEO, Michael Baker speaking to JustStocks about our iNKT cell therapy platform human clinical trial progress.
CEO Michael Baker’s interview with JustStocks
Previous
Previous
Spark Plus Singapore Healthcare Day Presentation
Next
Next